Back to Search
Start Over
P1214: SUBCUTANEOUS EPCORITAMAB + R-CHOP FOR FIRST-LINE TREATMENT OF PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: PHASE 1/2 UPDATE
- Source :
- HemaSphere. 6:1100-1101
- Publication Year :
- 2022
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2022.
- Subjects :
- Hematology
Subjects
Details
- ISSN :
- 25729241
- Volume :
- 6
- Database :
- OpenAIRE
- Journal :
- HemaSphere
- Accession number :
- edsair.doi...........f20b4825584c3fd0433528d16d5d31a1